anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
The uptake of human papillomavirus (HPV) vaccine remains suboptimal despite being a part of routine vaccination within national immunization program(s). This indicates probable challenges with the implementation of HPV immunization program(s) in various countries. The objective of this systematic literature review (SLR) was to identify implementation strategies for HPV vaccination within national and regional immunization programs worldwide with an aim to provide guidance for countries targeting to increase their HPV vaccine coverage rate (VCR). A comprehensive literature search was conducted across Medline and Embase and included articles published between January 2012 and January 2022. Of the 2,549 articles retrieved, 168 met inclusion criteria and were included in the review. Strategies shown to improve HPV vaccination uptake in the reviewed literature include campaigns to increase community awareness and knowledge of HPV, health care provider trainings, integrating HPV vaccination within school settings, coordinated efforts via multi-sectoral partnerships, and vaccination reminder and recall systems. Findings may help national authorities understand key considerations for HPV vaccination when designing and implementing programs aiming to increase HPV VCR in adolescents.
This is a Treatment Protocol for patients with severe and immediately life-threatening GBM that had surgical resection and first line treatment with radiation therapy and temozolamide per current standard of care. Patients will be treated with recurring 28-day cycles of ERC1671, GM-CSF, Cyclophosphomide, Bevacizumab, and Pembrolizumab until progression of disease and at the discretion of the treating physician.
PROBLEM TO BE SOLVED: To obtain the subject new compound having excellent antitumor activity with low toxicity and useful as an antitumor agent. SOLUTION: This condensed polycyclic heterocycle derivative is a compound expressed by formula I or its pharmacologically allowable salt [cycle A is a monocyclic aromatic ring or a dicyclic condensed ring having aromatic ring in at least one cycle; cycle B is pyrrole or 4H-1,4-oxazine, etc.; cycle C is a monocyclic or condensed dicyclic aromatic ring; Y is a group of formula -(e)-(f) ((e) is a lower alkylene; (f) is amidino or guanidino, etc.; excepting a case that both of the cycles A and C are each a monocyclic aromatic ring] and e.g. 5-[2-(dimethylamino)ethyl]-4H-benzo[C]pyrimido[5,6,1-(jk)]carbazole-4, 6(5H)-dione is exemplified.  The compound of the formula I is obtained by reacting a compound of formula II (cycle Aa and cycle Ca are each protectable cycle A or cycle C; cycle Ba is pyrrole, etc.; (fa) is a protectable (f)) with a compound of formula III (D and E are each a leaving group).
PURPOSE: To obtain a therapeutic medicine composition containing an anticancer platinum complex and an L-ascorbic acid compound, having a synergistic anticancer action, and enabling to reduce side effects and administration dose. CONSTITUTION: This therapeutic medicine composition contains (A) an anticancer platinum complex and (B) one of L-ascorbic acid, 5,6,0-benzylidene-L-ascorbic acid, 5,6,0-benzylideneL-ascorboic acid in which at least the 1-position of the aldehyde group of the benzylidene portion is substituted by deuterium, and their salts as active ingredients, and further contains a conventional excipient and a conventional carrier. Cisplatin as the active ingredient A and the active ingredient B are preferably added in amounts of 5-500mg and 100-10000mg. respectively. The ingredients A and B are preferably administered at dose s of 0.05-50mg and 10-10mg, respectively, per kg of body weight for an adult. The ingredient B contains a compound of the formula (X is H, a metal cation).
Gemcitabine + Erlotinib with radiation - Arm B: Gemcitabine 400 mg/M\^2 given intravenously over 40 min. every week for 6 doses beginning day 1 (days 1, 8, 15, 22, 29, 36) +/- 1 day. Erlotinib 100 mg daily by mouth on days 1-42. Radiation therapy 1 time each day for 5 days in a row for 5 1/2 weeks starting on Day 1 for a total of 50.4 Gy. Surgical removal of the pancreas and duodenum.
BACKGROUND: Perineal hernia (PH) is a late complication of abdominoperineal resection (APR) that may compromise a patient's quality of life. The frequency and risk factors for PH after robotic APR adopting recent rectal cancer treatment strategies remain unclear.
METHODS: Patients who underwent robotic APR for rectal cancer between December 2011 and June 2022 were retrospectively examined. From July 2020, pelvic reinforcement procedures, such as robotic closure of the pelvic peritoneum and levator ani muscles, were performed as prophylactic procedures for PH whenever feasible. PH was diagnosed in patients with or without symptoms using computed tomography 1 year after surgery. We examined the frequency of PH, compared characteristics between patients with PH (PH+) and without PH (PH-), and identified risk factors for PH.
RESULTS: We evaluated 142 patients, including 53 PH+ (37.3%) and 89 PH- (62.6%). PH+ had a significantly higher rate of preoperative chemoradiotherapy (26.4% versus 10.1%, p = 0.017) and a significantly lower rate of undergoing pelvic reinforcement procedures (1.9% versus 14.0%, p = 0.017). PH+ had a lower rate of lateral lymph node dissection (47.2% versus 61.8%, p = 0.115) and a shorter operative time (340 min versus 394 min, p = 0.110). According to multivariate analysis, the independent risk factors for PH were preoperative chemoradiotherapy, not undergoing lateral lymph node dissection, and not undergoing a pelvic reinforcement procedure.
CONCLUSIONS: PH after robotic APR for rectal cancer is not a rare complication under the recent treatment strategies for rectal cancer, and performing prophylactic procedures for PH should be considered.
Oral cavity cancer remains a significant cause of morbidity and mortality globally, with a poor prognosis once the disease has metastasized to cervical lymph nodes. The anatomy of lymphatic drainage in the neck gives us a roadmap to follow when assessing for metastasis, although the predictive factors are still not well understood. The mainstay of treatment continues to be neck dissection. However, there is much debate on the management of the clinically negative neck. The necessity of elective neck dissection has been questioned in recent years, with other options such as sentinel lymph node biopsy gaining popularity. This review will explore the aspects of surgical management of the neck in oral cavity cancer and highlights the further research that needs to be done.
Recently there has been renewed interest in potential alternative medical applications of cannabis/THC and medical marijuana is now legalized in 23 states and the District of Columbia. Acute effects of THC can include subjective feelings of euphoria, relaxation, and sedation, and clinicians noted that THC is well tolerated for its approved indications. Given these subjective effects and relatively benign safety profile, some physicians have used dronabinol (synthetic THC) "off-label" to treat depression and/or anxiety.

The investigators are doing this research to better understand how effective dronabinol treatment is when prescribed for depression and/or anxiety in older patients. The investigators also want to find out if dronabinol is safe to take without causing too many side effects. Dronabinol is is approved by the U.S. Food and Drug Administration (FDA) to treat loss of appetite in chemotherapy patients, but dronabinol is not approved by the FDA to treat depression and/or anxiety. Through research questionnaires on mood and cognition, the investigators can gather information that will help demonstrate how effective dronabinol treatment is at treating depression and/or anxiety.
PURPOSE:To obtain the titled vaccine comprising cells of Escherichia coli inactivated and then treated with ultrasonic waves. CONSTITUTION:Escherichia coli separated from the organ (e.g., air-sac) or feces of a fowl infected with colibacillosis is inactivated by a method using a chemical substance such as formalin, phenol, acetone or alcohol or by a method such as lyophilization or heat treatment. The inactivated Escherichia coli is subjected to an ultrasonic treatment to damage and destroy the cells of the Escherichia coli to give a vaccine for domestic fowl colibacillosis. The vaccine is sufficiently active even as it is, but it can be mixed with an adjuvant such as aluminum hydroxide gel or Freund's perfect adjuvant to improve the immunogenicity of the vaccine. It may be mixed and used in combination with other immune antigens or non-pathogenic antigens. The vaccine can be administered through various routes but is most preferably administered by a method of innoculating the vaccine into the anus of the domestic fowl because the method has no danger of generating a side-effect originated from bacterial toxicity.
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a disease of the nose and paranasal sinuses characterized by mucosal thickening and polyp formation. The prevalence of CRSwNP in the general population ranges between 1 and 4%. It mostly affects adult individuals. The treatment of CRSwNP can include the use of steroids, antibiotics, saline nasal spray, mucolytics, topical/systemic decongestants, topical anticholinergics, anti-leukotrienes or receptor blockers, and antihistamines. Steroids have a multitude of effects, including inhibition of cytokine synthesis, reduction of the number of eosinophils and activated eosinophils, anti-oedema effects and reduction of transudation. Topical corticosteroid therapy is not effective in all patients, leading to the use of systemic glucocorticosteroids and/or sinus surgery to control the disease. As a new approach, antibiotics are being used to treat CRSwNP particularly in patients with disease exacerbated by the Staphylococcus aureus enterotoxin. Antibiotics with anti- inflammatory effects can be used to treat patients with chronic rhinosinusitis without polyps, which might be the precursor to CRSwNP. Long-term treatment with these drugs, in selected cases, may be effective when corticosteroids fail. Doxycycline has dual action: it has well described, broad-spectrum antibacterial activity against S aureus as well as anti-inflammatory properties. It appears to be effective in treatment of several chronic inflammatory airway diseases.
Operations will be performed by one of two plastic surgeons who perform this surgery in a similar manner. The entire unilateral rectus abdominis muscle will be harvested with fascial-sparing as part of the pedicled TRAM flap. The flap will be shaped and sutured to the chest site, and the abdominal fascial defect will be closed primarily, followed by a polypropylene mesh overlay. Two 10 mm Jackson-Pratt (JP) drains will be placed in the flap wound, and two JPs will be placed in the abdominal wound. Immediately after transfer of the extubated patient to the recovery room bed, study devices will be placed on the reconstructed breast and abdominal donor sites, and activated. In the treatment arm, the PEMF signal is automatically delivered every two hours for fifteen minutes while the patient is in the hospital.
PURPOSE: Breast cancer (BC) treatment may affect pulmonary function, but evidence of long-term pulmonary toxicity is scarce. This study aimed to evaluate pulmonary function, radiation fibrosis (RF), and patient-reported dyspnea up to 12 years after different BC treatment modalities.
METHODS AND MATERIALS: Two hundred fifty patients with BC referred to postoperative radiotherapy (RT) were included in this study. High-resolution computed tomography, pulmonary function tests (PFTs), clinical examinations, and patient-reported dyspnea were assessed before RT and at 3, 6, and 12 months and up to 12 years after RT.
RESULTS: Vital capacity (VC), forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), and diffusion capacity of the lungs for carbon monoxide (DLCO) declined at 3 months after RT and remained low at long-term follow-up except for DLCO, which increased up to 12 years after RT. VC, FEV1, and FVC changes differed between patients treated with and without chemotherapy, and FEV1 differed between patients treated with locoregional and local RT. An early decline in VC, FEV1, and FVC predicted a late decline in PFT values up to 12 years after RT (P = .020, P = .004, and P = .020, respectively). RF, mainly grade 1, was observed in 91% of patients at long-term follow-up. Few patients reported severe dyspnea at long-term follow-up, and there was no statistically significant association with concurrent RF or decline in PFT values from baseline.
CONCLUSIONS: Chemotherapy and locoregional RT affected performance in PFTs up to 12 years after RT. Reduction in VC, FVC, and FEV1 3 months after RT predicted a decline in PFT values at long-term follow-up. However, a late decline in PFT values was not associated with long-term RF or patient-reported dyspnea.
Patients receive anthracycline once a day or split between 2-3 days per SOC. Patients undergo 2D-STE throughout the study and have their medical records reviewed on study.
Taking theophylline extended-release tablets immediately after ingesting a high fat content meal (45 g fat, 55 g carbohydrates, 28 g protein, 789 calories) may result in a somewhat higher Cmax and delayed Tmax and a somewhat greater extent of absorption when compared to taking it in the fasting state. The influence of the type and amount of other foods, as well as the time interval between drug and food, has not been studied.

The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinical use are immunoassays which are specific for theophylline. Other xanthines such as caffeine, dyphylline, and pentoxifylline are not detected by these assays. Some drugs (e.g.,cefazolin, cephalothin), however, may interfere with certain HPLC techniques. Caffeine and xanthine metabolites in neonates or patients with renal dysfunction may cause the reading from some dry reagent office methods to be higher than the actual serum theophylline concentration.
NEW MATERIAL:A 3-hydroxymethyl-2-phenylquinoline derivative shown by the formula I (R1 and R3 are lower alkyl; R2 is alkoxycarbonyl, R1, R2, and R3 are linked to 5, 6, and 7-positions or 6, 7, and 8-positions in this order). EXAMPLE:7-Ethoxycarbonyl-3-hydroxymethyl-6,8-dimethyl-2-phenylquinoline. USE:A preventive for thrombosis, and an improver for blood stream. A vasodilator, and an inhibitor of blood platelet aggregation. Effective for cerebral infarct, myocardial infarction, peripheral blood steam disorder, ischemic cerebral disoder, senile diemtia, etc. PREPARATION:A compound shown by the formula II is reacted with ethyl chloroformate in the presence of triethylamine, and the reaction product is reduced with a metal boron hydride, to give a compound shown by the formula I .
The present invention relates to a chronic nephritis pill which is searched and studied according to a traditional Chinese medicine theory. The chronic nephritis pill is mainly used for curing chronic nephritis and is prepared from psoralea fruit, white tuckahoe, white atractylodes rhizome, myrrh and centipede according to the proportion of 18 to 9 to 5 to 3 to 1. The psoralea fruit, the white tuckahoe, the white atractylodes rhizome, the myrrh and the centipede are uniformly mixed according to a certain amount and are prepared into a water-paste pill by yellow wine. 6 g of chronic nephritis pills are taken by an adult each time and thrice each day. During administration, raw and cold food, wine and sexual activities are forbidden. The chronic nephritis pill is cautiously used in pregnancy.
BACKGROUND: There is increasing interest in elucidating the relationship between adenoid hypertrophy (AH) and allergic rhinitis (AR). However, the impact of aeroallergen sensitization patterns on children with AH and AR remains unclear.
METHODS: Patients aged 2-8 years (recruited from January 2019 to December 2022) with nasal symptoms were assessed for allergies, adenoid size, and respiratory viral infection history. The serum total immunoglobulin E (IgE) and specific IgE levels were measured, and flexible nasal endoscopy was performed. The relationship between AH, aeroallergen sensitization patterns, and lymphocyte subpopulations in adenoid samples was analyzed using flow cytometry.
RESULTS: In total, 5281 children were enrolled (56.5% with AR; and 48.6% with AH). AH was more prevalent in children with AR. Compared to nonsensitized individuals, those polysensitized to molds had a higher prevalence of AH (adjusted OR 1.61, 95% CI 1.32-1.96) and a greater occurrence of two or more respiratory viral infections, particularly in adenoidectomy patients. The percentages and corrected absolute counts of regulatory T (Treg) cells, activated Tregs, class-switched memory B cells (CSMBs), natural killer (NK) T cells, and NK cell subpopulations were reduced in the adenoid tissues of children with both AH and AR (AH-AR) compared to AH-nAR children. Polysensitization in AH-AR children correlated with lower CSMB percentages.
CONCLUSION: Polysensitivity to molds is associated with an increased risk of AH in children with AR. Fewer B cells, NK cells, and Treg cells with an effector/memory phenotype were detected in the adenoids of AR children, and these lower percentages of immune cells, particularly CSMBs, were closely linked to aeroallergen sensitization models and respiratory viral infection.
The watercolor illusion (WCI) occurs when an achromatic region is surrounded by an outer contour and inner chromatic fringe, resulting in an apparent pale tint of the same hue as the fringe. The WCI both fills in and spreads out, with the previous literature suggesting it always spreads out in the absence of an enclosing border. We examined how global stimulus configuration affects this illusion by dissecting various WCI-inducing stimuli into parts. Specifically, would color spread out of the unenclosed ends of the disconnected parts? Participants provided WCI illusion magnitude ratings and shading data indicating perceived locations of color spreading for a variety of stimulus configurations. Instead of the WCI spreading modally into the spaces between the disconnected parts, we found a global reorganization of the stimuli occurred. The dissected WCI stimuli were perceived as either amodally completed behind a white illusory surface perceptually different than the physically identical background or, as empty space between separate objects depending in part on the distance between dissected parts. This study demonstrates the WCI does not always spread outside of unenclosed borders when the global interpretation interferes with spreading. These findings highlight the importance of global configuration and perceptual organization in the WCI.
A new method of designing and generating compounds having an increased probability of being drugs, drug candidates, or biologically active compounds, in particular having a therapeutic utility, is disclosed. The method consists of identifying a group of bioactive compounds, preferably of diverse therapeutic uses or biological activities and built on a common building block. In this group of compounds, side chains modifying the building block are identified and used to generate a second set of compounds according to the proposed methods of hybridization”, “single substitution” or “incorporation of frequently used side chains”. If the compounds in the second set built on the same building block contain an unusually large number of drugs, preferably with diverse therapeutic uses or biological activities, they constitute a “hot spot”. A focused combinatorial library of the “hot spot” is then generated, preferably by methods of combinatorial chemistry, and compounds of this library are screened for a variety of therapeutic uses or biological activities. The method generates drugs, drug candidates, or biologically active compounds with a high probability, without requiring any prior knowledge of biological targets.
Our objective was to present the perioperative and oncological results of robot-assisted surgery performed in our department. In our publication, we retrospectively reviewed the data of 658 robot-assisted procedures performed between 01/02/2022 and 31/03/2024. The average operative time for radical prostatectomy with bilateral lymph node block dissection was 229 minutes, mean blood loss was 305 ml. Without lymphadenectomy, mean blood loss was 233 ml, operative time was 185 minutes. Biochemical relapse- free rate was 81.6% one year after the procedures. 165 patients underwent robot-assisted partial nephrectomy, and 48 patients underwent radical nephrectomy. We performed the first robot-assisted cystectomy with intracorporeal "neobladder" technique in Hungary. In terms of urinary diversion, we performed orthotopic bladder formation in 10 cases, Bricker bladder formation in 20 cases, and uretherocutaneostomia in 4 cases. We also performed the first robot- assisted retroperitoneal lymphadenectomy in the country. As a conclusion, using robot-assisted technology, the full spectrum of radical uro-oncological surgical procedures can be safely performed in a minimally invasive manner. Our experience and results are encouraging so far, validating the increasing domestic distribution of robotic surgery.
PURPOSE:An immunerglator that contains, as an active ingredient, a specific benzazepine and its acid adduct other than diazepam and its acid adduct, thus being used for infections, malignant tumors and self-immune diseases, because of its immune-regulating actions. CONSTITUTION:The immuneregulator contains the compound of the formula (X is H, hydroxyl; Y is H, halogen), or its acid adduct as an active ingredient. For example, lorazepam (X is H, Y is C1) or oxazepam (X is hydroxyl, Y is H) is used. It is preferably given orally. The dose is 0.1-4mg/day, preferably 0.5-2mg/day. The compound of the formula direct acts on immunocytes to promote immune response.
Subjects will be asked to wear the lenses for 8 hours a day, at least 7 days a week. Contact lenses are worn and replaced every day. All subjects will be followed for 1 year after device allocation and will undergo brief clinical assessments at 1 day, 1 week, 1, 3, 6, 9, and 12 months.
Pelvic girdle pain (PGP) in pregnancy is common with prevalence estimates of 45%.1 It is defined as pain experienced between the posterior iliac crest and the gluteal fold, particularly in the region of the sacroiliac joint.2 Pain may radiate in the posterior thigh and can also occur in conjunction with/or separately in the symphysis. In PGP, the endurance capacity for standing, walking and sitting is diminished. The diagnosis of PGP can be reached after exclusion of lumbar causes and must be reproducible by specific clinical tests. While various pain mechanisms including mechanical, hormonal, inflammatory, and neural have been proposed in the development of PGP, the etiology and pathogenesis is poorly understood. It is possible that musculoskeletal changes influenced by hormonal (Relaxin) elevation in pregnancy predispose pregnant women to acute musculoskeletal injury presenting clinically as PGP. An inflammatory response in other acute musculoskeletal injuries has been well described3 and may also occur in pregnancy related PGP particularly given the musculoskeletal vulnerability during this time. Though PGP is common in pregnancy, no study to date has investigated the efficacy of anti-inflammatory treatment in pregnancy related PGP in order to better establish the contribution of inflammation in the etiology of pregnancy related PGP.